
The first case of this clinical trial was recently reported in the New York Times (https://www.nytimes.com/2019/04/13/health/implant-brain-injury.html), highlighting the interdisciplinary collaboration of researchers at the University of Utah, Stanford University, Weill Cornell Medicine, and Harvard Medical School. The results were also presented at the recent BRAIN Initiative Investigators Meeting in Washington, D.C. Andrew Janson, a SCI graduate student in the Biomedical Engineering PhD program, recently published a pipeline that allows interactive simulation and visualization of the effects of DBS. This approach was used to create a patient-specific model of this woman’s brain that was used for pre-operative surgical planning and post-operative management. The broad goal of this research is to increase the precision of DBS therapy, not only for patients suffering from traumatic brain injury but also for patients being treated using DBS for a range of other neurological and psychiatric conditions ranging from Tourette syndrome to epilepsy.
Janson, Andrew P., and Christopher R. Butson. 2018. “Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models.” Journal of Visualized Experiments, no. 138(August). doi:10.3791/57292.